Breakfast Event | 24 May 2019 | FRORIEP Geneva
10 May 2019
FRORIEP is pleased to invite you to a breakfast on Friday, 24 May 2019 on:
How can impact investing contribute to closing the financing gap for the world’s largest killer – chronic disease?
Dr. Andrea Feigl, PhD MPH, founder of the Health Finance Institute and a visiting scientist and health economist at Harvard TH Chan School of Public Health, will highlight the investment case for chronic diseases, how the Health Finance Institute is working with the WHO HL Commission for NCDs to design a global catalytic fund for Noncommunicable diseases (NCDs) to support the design of a global catalytic fund for NCDs, and how this area represents an opportunity for innovative and social impact investing.
WHO predicts major economic losses over $500 billion a year in low and middle-income countries if NCDs are not addressed. Despite great human and economic toll from NCDs, overall prevention spending for the top NCDs - cancer, cardiovascular disease, chronic lung disease and diabetes - only command about 1 percent of global health funding. As countries continue to progress towards universal Sustainable Development Goal 3, better and increased health financing has been critical to ensure individuals have access to affordable and quality health care without risk of financial hardship. However, despite efforts to improve public financial management and health financing, gaps remain in public and private sector financing, particularly as global health priorities and burdens shift.
This event will provide an overview and discussion of innovative financing models and how they can be applied to address the global economic burden of chronic disease.
- 08:30 Arrival
- 08:35 Welcome
- 08:40-10:00 Presentation by Dr. Andrea Feigl
- Venue: FRORIEP | 4, Rue Charles-Bonnet | 1206 Genève
- Registration: by Friday 17 May 2019 by email to Laura Gyger
Please note as the number of places is limited, the registration is made on a "first come – first served" basis.